TITLE

SKB Ponders Block Moves

AUTHOR(S)
Bittar, Christine
PUB. DATE
October 2000
SOURCE
Brandweek;10/16/2000, Vol. 41 Issue 40, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the acquisition of Block Drug by SmithKline Beecham. Estimated value of the deal; Products manufactured by Block Drug; Pay scheme for employee termination and relocation offered by Block Drug.
ACCESSION #
3732826

 

Related Articles

  • SB to Buy Block Drug for $1.24 Bn To Strengthen Consumer Health.  // Chemical Market Reporter;10/16/2000, Vol. 258 Issue 16, p16 

    Reports that SmithKline Beecham (SB) has agreed to acquire Block Drug Co. Incorporated. Intention behind the purchase; Gain from the acquisition; Key oral care products offered by SB.

  • SmithKline Beecham to acquire Block Drug. Scalise, Annette // Drug Store News;10/30/2000, Vol. 22 Issue 16, p32 

    Announces the agreement of SmithKline Beecham to acquire Block Drug Co. Inc. Terms of the agreement; Significance of the acquisition; Sales performance of both companies.

  • Block Sold for Billion Plus. Palmer, Paul R. // Access;Jan2001, Vol. 15 Issue 1, p47 

    Reports the acquisition of Block Drug Company by Smithkline Beecham (SB). Enhancement of SB's health care business; Strategies for corporate growth; Details on the operations of both companies.

  • News Bites.  // Drug Store News;11/29/99, Vol. 21 Issue 19, p29 

    Presents updates on drugstore-related issues in the United States as of November 29, 1999. Merger transaction between American Home Products company and Warner-Lambert company; Relaunching of the Contac 12-Hour Cold Capsules, a multi-market promotion organized by SmithKline Beecham company;...

  • American Home Products considers a huge merger. Goldblatt, Dan // Business News New Jersey;01/26/98, Vol. 11 Issue 4, p1 

    Reports on a potential merger between American Home Products company of New Jersey and SmithKline Beecham company of London, England. Information on the companies' stock prices; Comments from David Saks, senior vice president at Gruntal and Company; Estimated annual savings of the combined...

  • Corporate egos reject logic to hasten mergers made in hell. Pitcher, George // Marketing Week (01419285);3/19/1998, Vol. 21 Issue 3, p25 

    Presents information on mega mergers in companies, and their fallibilities, referencing SmithKline Beecham, which spurned American Home Products in favour of having Glaxo Wellcome as a mega-partner. Reference to United States anti-trust authorities; Detailed information on mega merger in companies.

  • GlaxoSmithKline Merger Completed As Trading for New Company Begins.  // Chemical Market Reporter;01/01/2001, Vol. 259 Issue 1, p11 

    Reports that GlaxoSmithKline PLC, the merger company of Glaxo Wellcome and SmithKline Beecham, has began trading on the New York and London Stock Exchanges following the completion of the merger process in December 2000. Approval of the merger; Sales of GlaxoSmithKline; Products of the merged...

  • Glaxo, SmithKline merger would create pharmaceutical powerhouse. Roller, Kim // Drug Store News;2/21/2000, Vol. 22 Issue 2, p29 

    Reports on the proposed merger of Glaxo Wellcome PLC and SmithKline Beecham PLC. Market capitalization and percentage share of the global pharmaceutical market to be assumed by the merger; Views from Andrew Fenton, a pharmaceutical industry analyst with PriceWaterhouseCoopers; Combined sales of...

  • `Slick' new company eyes medical diagnostics market. Lehrman, Sally // Nature;9/11/1997, Vol. 389 Issue 6647, p107 

    Reports that Incyte Pharmaceuticals Inc. and SmithKline Beecham (SKB) are creating a joint venture company called diaDexus. Goal of diaDexus to discover and commercialize molecular diagnostic products; Use of bioformatics and genomics to develop tests for disease detection; How both companies...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics